Shawn Titcomb
Director/Board Member en Praesidia Biotherapeutics, Inc. .
Fortuna: 6 M $ al 31/03/2024
Perfil
Shawn M.
Titcomb was the founder of ZyVersa Therapeutics Operating, Inc. founded in 2014, where he held the title of Chairman.
Currently, he is an Independent Director at Praesidia Biotherapeutics, Inc. since 2021.
Previously, he worked as a Managing Director at Noble Capital Markets, Inc. from 2000 to 2012.
He also served as a Director at Coya Therapeutics, Inc., a Partner at Variant Trading Institutional Group, Inc., and a Vice President at Avalon Research Group, Inc. Mr. Titcomb obtained his undergraduate degree from the University of Denver.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COYA THERAPEUTICS, INC.
2.30% | 29/12/2022 | 333 826 ( 2.30% ) | 3 M $ | 31/03/2024 |
GAIN THERAPEUTICS, INC.
4.50% | 10/04/2023 | 729 737 ( 4.50% ) | 3 M $ | 31/03/2024 |
Cargos activos de Shawn Titcomb
| Empresas | Cargo | Inicio |
|---|---|---|
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Director/Board Member | 01/07/2021 |
Antiguos cargos conocidos de Shawn Titcomb.
| Empresas | Cargo | Fin |
|---|---|---|
Noble Capital Markets, Inc.
 Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Corporate Officer/Principal | - |
| COYA THERAPEUTICS, INC. | Director/Board Member | - |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Founder | - |
| Avalon Research Group, Inc. | Sales & Marketing | - |
Variant Trading Institutional Group, Inc.
 Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Sales & Marketing | - |
Formación de Shawn Titcomb.
| University of Denver | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COYA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Noble Capital Markets, Inc.
Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Finance |
Variant Trading Institutional Group, Inc.
Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Finance |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
| Avalon Research Group, Inc. | Finance |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
- Bolsa de valores
- Insiders
- Shawn Titcomb
